HGH
Recombinant human growth hormone (somatropin) — a bioidentical hormone, not a signaling peptide, researched for recovery, fat loss, and regeneration.
What It Is
HGH (Human Growth Hormone), also known as somatropin, is a bioidentical hormone researched for recovery, fat loss, muscle preservation, and overall regeneration. Unlike GHRH/GHRP peptides such as CJC-1295, Ipamorelin, Tesamorelin, or Sermorelin, HGH supplies growth hormone directly rather than stimulating the pituitary to release more of its own.
It works by increasing IGF-1 levels, which drives many of the body’s repair and growth processes — increased protein synthesis, enhanced fat metabolism, and improved cellular repair and recovery.
Who May Benefit
- Fat loss and body recomposition research
- Recovery from intense training or injury
- Anti-aging protocols
- Research involving low baseline GH/IGF-1 levels
What to Expect
HGH works slowly — meaningful changes tend to unfold over months, not days. Community-reported timelines (not published clinical data) generally describe: improved sleep and some water retention in weeks 1–4; noticeable fat loss and improved recovery by weeks 4–8; visible body-composition and skin/hair changes by months 2–3; peak recomposition effects by months 3–6.
Low-dose HGH (1–2 IU/day) is generally framed as restoring levels closer to what the body produced natively, with side effects considered more manageable. Higher doses (4+ IU/day) push levels above natural physiological range, which may produce more dramatic body-composition changes but with a higher likelihood of side effects.
What to Pair It With
Reconstitution
Specific reconstitution figures for this compound weren’t included in the source material. Reconstitution ratios vary by vial size and intended concentration — use a peptide reconstitution calculator and consult your research protocol source before proceeding.
Suggested Research Dosing Strategy
Administration Notes
HGH is a prescription medication in most jurisdictions and should be used under medical supervision where applicable.
Monitor blood glucose and edema (water retention) throughout any research protocol.
More is not automatically better with HGH — doses well above physiological replacement range carry meaningfully higher side-effect risk.
Research Considerations
Because HGH is direct hormone replacement rather than a signaling peptide, its research and risk profile differ meaningfully from GHRH/GHRP compounds like Tesamorelin or Ipamorelin, which rely on a functioning pituitary response and are generally self-limiting by comparison.
This is the one compound on this page where the case for close monitoring and, where applicable, medical supervision is strongest.
Have a specific question about HGH? Chat with Pulse, Signal IQ’s free AI research assistant — ask about mechanisms, stacking, or how it compares to other compounds.